VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $11,763,000 | -7.7% | 506,140 | -36.7% | 0.24% | +15.6% |
| Q1 2018 | $12,742,000 | -39.7% | 800,104 | -21.4% | 0.20% | -45.6% |
| Q4 2017 | $21,136,000 | +2058.9% | 1,017,300 | +1385.1% | 0.38% | +2413.3% |
| Q3 2017 | $979,000 | -59.5% | 68,500 | -51.0% | 0.02% | -58.3% |
| Q2 2017 | $2,417,000 | +47.3% | 139,700 | -6.1% | 0.04% | +50.0% |
| Q1 2017 | $1,641,000 | +197.3% | 148,755 | +290.6% | 0.02% | +140.0% |
| Q4 2016 | $552,000 | -79.1% | 38,083 | -64.6% | 0.01% | -76.2% |
| Q3 2016 | $2,642,000 | +294.9% | 107,700 | +323.5% | 0.04% | +281.8% |
| Q1 2016 | $669,000 | +149.6% | 25,432 | +1595.5% | 0.01% | +175.0% |
| Q3 2015 | $268,000 | -98.5% | 1,500 | -98.9% | 0.00% | -98.3% |
| Q3 2014 | $18,232,000 | -52.7% | 138,963 | -54.6% | 0.24% | -48.7% |
| Q2 2014 | $38,580,000 | – | 305,899 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |